Clinical evaluation of blue-light blocker foldable acrylic IOL (HMY)
- 10 Downloads
Efficacy and safety of blue-light-filtering acrylic IOL (HMY) were assessed and proven from 3 months to 1 year of postoperative follow-up in a clinical study performed on 80 eyes of 45 patients. Postoperative corrected visual acuity of all the eyes was 6/12 or better and 78.8% of them achieved higher than 6/6. The rate of mean corneal endothelial cell density decrease stood at 5.0%. Mild complciations were observed, but none were serious.
KeywordsVisual Acuity Anterior Chamber Color Vision Intraocular Lens Subconjunctival Injection
Unable to display preview. Download preview PDF.